COVID-19

Approximately 2 years after patients were infected with COVID-19, non-hospitalized patients suffered from post-COVID-19 symptoms nearly 8% more than hospitalized patients.

Although long-term health issues from COVID-19 are a major public health concern, evidence on post-acute COVID-19 syndrome, or post-COVID-19, is still limited, specifically among children and adolescents.

Individuals with COVID-19 reinfections were twice as likely to die and three times more likely to be hospitalized than those who did not have COVID-19 multiple times.

Both of Moderna's bivalent boosters showed neutralizing activity against BQ.1.1, an increasingly dominant emerging variant, confirming that updated vaccines have the potential to offer protection as the virus continues to evolve.

Like using good nutrients to grow tomatoes in the soil, good nutrients and diverse microbes are important for our good gut health, or our gut's "garden," said a leading researcher.

In a 2019 survey, middle-aged participants were considerably more apprehensive about getting vaccinated than younger groups, which was not the case in the 2022 survey.

In recent years, pharmacist roles have evolved as critically important caregivers who increasingly provide essential health care services far beyond medication dispensing.

NVX-CoV2373 is a protein-based vaccine developed from the genetic sequence of the first strain of SARS-CoV-2.

New COVID-19 variants are always cause for concern but are not a cause for panic.

Despite evidence of a higher risk of myocarditis or pericarditis with COVID-19 vaccination, immunization should still be recommended because the benefits likely outweigh the harms, study shows.

The book aims to make the vaccination process less scary and allow more children to be vaccinated.

In 2020, heart disease death rates increased in adults across all age, sex, racial and ethnic groups, specifically among younger adults and non-Hispanic Black adults.

A 30-µg booster dose of the Omicron BA.4/BA.5-adapted bivalent vaccine may produce a higher level of protection against the Omicron BA.4 and BA.5 sublineages than the original COVID-19 vaccine.

A session presenter at the ASCP 2022 Annual Meeting explained how the COVID-19 pandemic significantly magnified the importance of infection prevention and control practices in long-term care.

In addition to the ongoing COVID-19 pandemic, significant public health concerns include opioid overdoses, maternal mortality disparities, and climate change.

Pharmacy leaders and academics have been begging the profession to evolve for decades. It took a pandemic to make it happen.

Double-digit inflation, low reimbursement rates, and staffing shortages present obstacles.

The vaccine is suggested to cause more rare cases of thrombosis with thrombocytopenia syndrome than the mRNA-based vaccine, especially among younger individuals.

Last year in particular, pharmacists played a greater role in patient care with an increased workload as they connected patients, providers, and payers.

Findings are encouraging for individuals with cancer who are receiving immune checkpoint inhibition treatment and want to get a third vaccine dose, investigators said.

Study results indicate durable immune response from bivalent booster after 3 months of follow-up.

Highest prevalence is seen among adults, outpatients, and women and can cause persistent severe anosmia or hyposmia, findings indicate.

The Moderna mRNA-1273 vaccine was found to be effective for more than 50% of children aged 6 to 23 months.

People with anxiety and related disorders were found to have vaccine hesitancy related to concerns regarding adverse effects and efficacy.

A researcher suggests that the levels of certain gut bacteria can predict the severity of symptoms that someone can experience when infected with COVID-19.